| Literature DB >> 27387137 |
Thomas Hofmann1, Lan Ma-Hock1, Volker Strauss1, Silke Treumann1, Maria Rey Moreno1, Nicole Neubauer2, Wendel Wohlleben2, Sibylle Gröters1, Karin Wiench3, Ulrich Veith4, Wera Teubner5, Bennard van Ravenzwaay1, Robert Landsiedel1.
Abstract
Diketopyrrolopyrroles (DPP) are a relatively new class of organic high-performance pigments. The present inhalation and particle characterization studies were performed to compare the effects of five DPP-based pigments (coarse and fine Pigment Red 254, coarse and fine meta-chloro DPP isomer and one form of mixed chlorinated DPP isomers) and compare it to coarse and fine inorganic Pigment Red 101. Wistar rats were exposed head-nose to atmospheres of the respective materials for 6 h/day on 5 consecutive days. Target concentrations were 30 mg/m(3) as high dose for all compounds and selected based occupational exposure limits for respirable nuisance dust. Toxicity was determined after end of exposure and after 3-week recovery using broncho-alveolar lavage fluid (BALF) and microscopic examinations of the entire respiratory tract. Mixed chlorinated DPP isomers and coarse meta-chloro DPP isomer caused marginal changes in BALF, consisting of slight increases of polymorphonuclear neutrophils, and in case of coarse meta-chloro DPP increased MCP-1 and osteopontin levels. Mixed chlorinated DPP isomers, Pigment Red 254, and meta-chloro DPP caused pigment deposits and phagocytosis by alveolar macrophages, slight hypertrophy/hyperplasia of the bronchioles and alveolar ducts, but without evidence of inflammation. In contrast, only pigment deposition and pigment phagocytosis were observed after exposure to Pigment Red 101. All pigments were tolerated well and caused only marginal effects in BALF or no effects at all. Only minor effects were seen on the lung by microscopic examination. There was no evidence of systemic inflammation based on acute-phase protein levels in blood.Entities:
Keywords: Diketopyrrolopyrrole; inhalation toxicity; iron oxide; pigments; short-term inhalation toxicity test
Mesh:
Substances:
Year: 2016 PMID: 27387137 PMCID: PMC5020341 DOI: 10.1080/08958378.2016.1200698
Source DB: PubMed Journal: Inhal Toxicol ISSN: 0895-8378 Impact factor: 2.724
Test materials.
| Compound | CAS No. | Analytical characterization | Producer |
|---|---|---|---|
| Mixed chlorinated DPP isomers | 84632-67-7 and 88949-44-4 (isomers), 84632-65-5 (mixture) | Extractable fraction <0.4% | BASF Schweiz AG, Switzerland |
| Fine Pigment Red 254 | 84632-65-5 | Extractable fraction 0.5% | BASF Schweiz AG, Switzerland |
| Coarse Pigment Red 254 | 84632-65-5 | Extractable fraction 0.5% | BASF Schweiz AG, Switzerland |
| Coarse | 84632-67-7 | Purity 98.02% | BASF Schweiz AG, Switzerland |
| Fine | 84632-67-7 | Purity 98.04% | BASF Schweiz AG, Switzerland |
| Fine Pigment Red 101 | 1309-37-1 | Iron content 62 g/100 g | BASF SE, Germany |
| Coarse Pigment Red 101 | 1309-37-1 | Not characterized | Huntsman, Italy |
Figure 1. Generic formula of the DPP pigments.
Physico-chemical parameters of the test materials.
| Pigment | Size in nm (d50) (TEM) | Surface in m2/g (BET) | Composition (elements in %) (oxidation, XRD, XRF) | Surface chemistry (elements in %) (XPS) | Reactivity (in μUFRAS/m2h) (FRAS) | Dissolution in water (ICP-MS, UV/Vis) | Dispersibility in DMEM-FCS (d50) (AUC-XLA) | Charge in mV (zeta potential) | Hydrophobicity (contact Angle) | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mixed chlorinated DPP isomers | 39 | 62 | C 60.5, H 2.9, N 7.8, O 9.1, Cl 19.6; amorphous and crystalline; no contaminations >0.1% | C 74.8, O 8.1, N 8.3, Cl 8.9 | <1 ppm | 988 nm, AAN: 25 | N/A | Hydrophobic (138°) | ||
| Fine Pigment Red 254 | 43 | 94 | C 60.9, H 2.8, N 7.8, O 9.0, Cl 19.9; no contaminations >0.1% Si, Br <0.1% | C 77.1, O 10.9, N 5.9, Cl 6.1 | Non-active (0.0006) | ≪1 ppm | 774 nm, AAN: 18 | −16 | Hydrophobic (135°) | |
| Coarse Pigment Red 254 | 233 | 16 | C 60.5, H 2.8, N 7.8, O 8.9, Cl 19.7; no contaminations >0.1% Si, Br <0.1% | C 79.4, O 10.0, N 5.1, Cl 5.2, | Non-active (0.0007) | <1 ppm | 352 nm, AAN: 1.5 | -41 | Hydrophobic (136°) | |
| Coarse | 0.3–3 μm × 70–200 nm | 42 | C 60.4, H 2.9, N 7.8, O 9.1, Cl 19.8; no contaminations >0.1% | C 73.1, O 8.4, N 9.5, Cl 9, | Intermediate (0.0196) | ≪1 ppm | ≫1 μm, AAN > 10 | −11 | Hydrophobic (110°) | |
| Fine | 30–400 nm × 10-50 nm | 64 | C 60.6, H 2.9, N 7.9, O 9.0, Cl 19.6; no contaminations >0.1% | C 73.6, O: 8.8, N 8.7, Cl 8.8 | Intermediate (0.0256) | ≪1 ppm | ≫1 μm, AAN > 33 | −12 | Hydrophobic (141°) | |
| Fine Pigment Red 101 | 15–130 nm× 4–21 nm | 107 | Fe2O3, hematite | O 54.2, Fe 27.2, C 15.7, P 1.6, Ca 0.9, S 0.2, F 0.1, Mg 0.1 | Intermediate (0.0372) | <1 ppm | >1 μm, AAN > 1000 | −27 | Hydrophilic (0°) | |
| Coarse Pigment Red 101 | 48–90 nm | 12 | predominantly Fe2O3, hematite; possibly also Fe3O4 magnetite | O 49.6, Fe 24.6, C 23.9, Na 1.9 | Intermediate (0.0200) | <1 ppm | >1 μm, AAN > 20 | −55 | Hydrophilic (0°) |
TEM: transmission electron microscopy; BET: Brunauer–Emmet–Teller; XRD: X-ray diffraction; XRF: X-ray fluorescence; XPS: X-ray photoelectron spectroscopy; FRAS: ferric reducing ability of serum; ICP-MS: inductively coupled plasma mass spectrometry; AUC-XLA: analytical ultracentrifuge; AAN: average agglomeration number.
Charge of mixed chlorinated DPP isomers is not detectable by the used measurement technique.
Figure 2. Study design: X, head–nose exposure for 6 h/day on 5 consecutive days, R, post-exposure time; H, histology of selected organs; L, examination of blood and broncho-alveolar lavage fluid (BALF).
Figure 3. Schematic picture of the inhalation exposure system.
Figure 4. Representative electron microscopy images of the five organic pigments. Mixed chlorinated DPP isomers (A), fine Pigment Red 254 (B), coarse Pigment Red 254 (C), fine meta-chloro DPP (D) and coarse meta-chloro DPP (E) and the two inorganic fine Pigment Red 101 (F) and coarse Pigment Red 101 (G).
Results of gravimetric determination of test atmosphere concentration and particle size distribution.
| Mixed chlorinated DPP isomers | |||
| Target concentration (mg/m3) | 30 | ||
| Measured concentration (mg/m3±SD) | 31.49 ± 1.27 | ||
| MMAD (μm) | 0.7/0.6 | ||
| GSD | 2.6/2.8 | ||
| OPC | |||
| Count median diameter (μm) | 0.376 | ||
| Count concentration (N/cm3) | 94 423 | ||
| SMPS | |||
| Count median diameter (μm) | 0.292 | ||
| Count concentration (N/cm3) | 373 840 | ||
| Target concentration (mg/m3) | 30 | ||
| Measured concentration (mg/m3±SD) | 29.86 ± 2.77 | ||
| MMAD (μm) | 1.1/0.6 | ||
| GSD | 2.5/3.2 | ||
| OPC | |||
| Count median diameter (μm) | 0.362 | ||
| SMPS | |||
| Count concentration (N/cm3) | 63 792 | ||
| Count median diameter (μm) | 0.255 | ||
| Target concentration (mg/m3) | 30 | ||
| Measured concentration (mg/m3±SD) | 31.34 ± 4.49 | ||
| MMAD (μm) | 0.7/0.7 | ||
| GSD | 2.9/2.5 | ||
| OPC | |||
| Count median diameter (μm) | 0.370 | ||
| Count concentration (N/cm3) | 191 421 | ||
| SMPS | |||
| Count median diameter (μm) | 0.255 | ||
| Count concentration (N/cm3) | 506 049 | ||
| Target concentration (mg/m3) | 3 | 10 | 30 |
| Measured concentration (mg/m3±SD) | 3.45±.23 | 10.54 ± 1.54 | 31.04 ± 3.11 |
| MMAD (μm) | 0.7/0.9 | 0.6/0.6 | 1.1/0.8 |
| GSD | 2.8/2.4 | 2.9/3.1 | 2.6/2.5 |
| OPC | |||
| Count median diameter (μm) | 0.498 | 0.605 | 0.589 |
| Count concentration (N/cm3) | 18 987 | 63 792 | |
| SMPS | |||
| Count median diameter (μm) | 0.366 | 0.409 | 0.359 |
| Count concentration (N/cm3) | 96 924 | 33 168 | 115 116 |
| Target concentration (mg/m3) | 3 | 10 | 30 |
| Measured concentration (mg/m3±SD) | 3.55 ± 0.30 | 13.97 ± 1.58 | 32.00 ± 5.19 |
| MMAD (μm) | 1.1/1.1 | 0.7/0.7 | 0.9/0.9 |
| GSD | 2.8/2.6 | 3.1/2.8 | 2.7/2.7 |
| OPC | |||
| Count median diameter (μm) | 0.380 | 0.366 | 0.389 |
| Count concentration (N/cm3) | 6322 | 25 819 | 96 507 |
| SMPS | |||
| Count median diameter (μm) | 0.263 | 0.242 | 0.233 |
| Count concentration (N/cm3) | 35 004 | 178 400 | 506 463 |
| Target concentration (mg/m3) | 10 | 30 | |
| Measured concentration (mg/m3±SD) | 11.3 ± 1.7 | 29.5 ± 6.5 | |
| MMAD (μm) | 3.0/2.3 | 2.1/2.8 | |
| GSD | 3.1/2.5 | 2.8/2.1 | |
| OPC | |||
| Count median diameter (μm) | 0.347 | 0.348 | |
| SMPS | |||
| Count concentration (N/cm3) | 9712 | 28 502 | |
| Count median diameter (μm) | 0.233 | 0.233 | |
| 77 062 | 156 058 | ||
| 30 | |||
| Target concentration (mg/m3) | 26.8 ± 3.9 | ||
| Measured concentration (mg/m3±SD) | 0.9/0.9 | ||
| MMAD (μm) | 3.6/4.9 | ||
| GSD | 0.292 | ||
| OPC | |||
| Count median diameter (μm) | 90 462 | ||
| Count concentration (N/cm3) | 0.198 | ||
| SMPS | |||
| Count median diameter (μm) | 833 882 | ||
| Count concentration (N/cm3) | 30 | ||
OPC: optical particle counter; SMPS: scanning mobility particle sizer.
Cytology parameters in BALF after exposure to mixed chlorinated DPP isomers.
| Study day 8 | Study day 29 | |
|---|---|---|
| Concentration (mg/m3) | 30 | 30 |
| Polymorphonuclear Neutrophils | 7.0 | 1.0 |
Differences are expressed as x-fold ratios compared to the concurrent control group.
*Statistically significant, p < 0.05.
Figure 5. Individual values of polymorphonuclear neutrophils in BALF. Only four animals were evaluated at 30 mg/m³.
Figure 6. Individual values of polymorphonuclear neutrophils, osteopontin and MCF-1 in BALF.
Mediators in BALF after exposure to fine meta-chloro DPP.
| Study day 8 | Study day 29 | |||||
|---|---|---|---|---|---|---|
| Concentration (mg/m3) | 3 | 10 | 30 | 3 | 10 | 30 |
| CINC-1/IL-8 | 0.9 | 1.2 | 2.9** | 0.8 | 1.2 | 2.8 |
| Osteopontin | 0.7 | 0.8 | 2.4 | 2.1 | 2.8 | 0.9 |
Differences are expressed as x-fold ratios compared to the concurrent control group.
*Statistically significant, p < 0.05; **statistically significant, p < 0.01.
Summary of organ weights (three animals per group, day 5).
| Compound/organ | Coarse Pigment Red 254 | Coarse | ||||
|---|---|---|---|---|---|---|
| Concentration (mg/m³) | 0 | 30 | 0 | 3 | 10 | 30 |
| Adrenal gland | ||||||
| Absolute (mg) | 57.3 | 70.0 | ||||
| Relative (%) | 0.023 | 0.03 | ||||
| Thymus | ||||||
| Absolute (mg) | 435.7 | 395.3 | 329.3 | 279.3 | ||
| Relative (%) | 0.177 | 0.158 | 0.138 | 0.121 | ||
Incidence of treatment-related microscopic findings – day 5.
| Examined organs/microscopic findings | Mixed chlorinated DPP isomers | Fine Pigment Red 254 | Coarse Pigment Red 254 | Fine meta-chloro DPP | Coarse meta-chloro DPP | Fine Pigment Red 101 | Coarse Pigment Red 101 | |||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Concentration (mg/m³) | 30 | 30 | 30 | 3 | 10 | 30 | 3 | 10 | 30 | 10 | 30 | 30 |
| No. of animals/group | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 |
| Lung | ||||||||||||
| Pigment-laden macrophages | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 |
| Hypertrophy/hyperplasia, epithelial, terminal bronchioles | 3 | 3 | 3 | 0 | 2 | 3 | 0 | 3 | 3 | 0 | 0 | 0 |
| Pigment-laden macrophages and/or particles in BALT | 0 | 0 | 3 | 1 | 1 | 3 | 0 | 0 | 3 | 3 | 3 | 3 |
| Mediastinal/tracheobronchial lymph nodes | ||||||||||||
| Pigment-laden macrophages and/or particles | 3 | 3 | 0 | 0 | 0 | 2 | 0 | 0 | 3 | 3 | 3 | |
| Nasal cavity | ||||||||||||
| Pigment-laden macrophages/pigment particles, luminal | 2 | 3 | 3 | 0 | 2 | 2 | 0 | 0 | 3 | 0 | 0 | |
| Larynx | ||||||||||||
| Pigment-laden macrophages/pigment particles, luminal | 0 | 1 | 2 | 0 | 2 | 1 | 0 | 0 | 1 | 0 | 0 | |
| Trachea | ||||||||||||
| Pigment particles, luminal | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3 | 0 | 0 | |
Not examined.
Figure 7. Histopathological findings in the lung of animals treated with coarse meta-chloro DPP pigment (30 mg/m³) after 5 days (A and B) and after a 3-week recovery period (C); H&E, 200×. (A) Terminal bronchiole of a control animal. (B) Epithelial hypertrophy of the terminal bronchiole and increased number of pigment-laden macrophages in a treated animal. (C) Regression of the epithelial hypertrophy of the terminal bronchiole and reduction of the number of pigment-laden macrophages.
Cytology parameters in BALF after exposure to coarse meta-chloro DPP.
| Study day 8 | Study day 29 | |||||
|---|---|---|---|---|---|---|
| Concentration (mg/m3) | 3 | 10 | 30 | 3 | 10 | 30 |
| Total cells | 0.8 | 0.8 | 2.3 | 0.9 | 1.2 | 0.9 |
| Polymorphonuclear neutrophils | 0.2 | 2.2 | 83.9 | 0.2 | 0.2 | 1.0 |
Differences are expressed as x-fold ratios compared to the concurrent control group.
*Statistically significant, p < 0.05.
Protein concentration and enzyme activities in BALF after exposure to coarse meta-chloro DPP.
| Study day 8 | Study day 29 | |||||
|---|---|---|---|---|---|---|
| Concentration (mg/m3) | 3 | 10 | 30 | 3 | 10 | 30 |
| Total protein | 1.2 | 0.8 | 2.1 | 1.2 | 1.1 | 1.1 |
| GGT | 1.6 | 1.0 | 3.8 | 4.8 | 2.4 | 5.8 |
| LDH | 1.5 | 1.0 | 3.1 | 0.9 | 1.2 | 1.2 |
| ALP | 1.2 | 1.1 | 2.0 | 1.0 | 1.2 | 1.5 |
Differences are expressed as x-fold ratios compared to the concurrent control group.
*Statistically significant, p < 0.05.
Mediators in BALF after exposure to coarse meta-chloro DPP.
| Study day 8 | Study day 29 | |||||
|---|---|---|---|---|---|---|
| Concentration (mg/m3) | 3 | 10 | 30 | 3 | 10 | 30 |
| MCP-1 | 0.8 | 0.9 | 12.2 | 1.0 | 1.0 | 2.0 |
| CINC-1/IL-8 | 1.3 | 1.3 | 2.2 | 1.0 | 1.2 | 1.7 |
| Osteopontin | 1.2 | 2.3 | 13.9 | 0.8 | 1.4 | 1.7 |
Differences are expressed as x-fold ratios compared to the concurrent control group.
*Statistically significant, p < 0.05.
Incidence of treatment-related microscopic findings – day 26.
| Examined organs/microscopic findings | Mixed chlorinated DPP isomers | Fine Pigment Red 254 | Coarse Pigment Red 254 | Fine meta-chloro DPPa | Coarse meta-chloro DPP | Fine Pigment Red 101 | Coarse Pigment Red 101 | |||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Concentration (mg/m³) | 30 | 30 | 30 | 3 | 10 | 30 | 3 | 10 | 30 | 10 | 30 | 30 |
| No. of animals/test group | 3 | 3 | 3 | 3 | 3 | 2 | 3 | 3 | 3 | 3 | 3 | 3 |
| Lung | ||||||||||||
| Pigment-laden macrophages, decreased (compared to day 5) | 3 | 3 | 3 | 3 | 3 | 2 | 0 | 0 | 3 | 3 | 3 | 3 |
| Pigment-laden macrophages and/ or particles in BALT | 3 | 3 | 3 | 3 | 3 | 1 | 0 | 0 | 3 | 3 | 3 | 3 |
| Mediastinal/tracheobronchial lymph nodes | ||||||||||||
| Pigment-laden macrophages/pigment particles | 3 | 3 | 2 | 0 | 3 | 2 | 0 | 3 | 3 | 2 | 3 | 2 |
| Lymphoreticular hyperplasia | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 0 | 0 | 0 |
| Nasal cavity | ||||||||||||
| Pigment particles, luminal | 0 | 1 | 0 | |||||||||
| Larynx | ||||||||||||
| Pigment-laden macrophages/pigment particles, luminal | 0 | 0 | 0 | 0 | 2 | 0 | ||||||
| Trachea | ||||||||||||
| Pigment-laden macrophages/pigment particles, luminal | 0 | 0 | 0 | |||||||||
Not examined.